Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix

被引:71
作者
Jankovic, B
Aquino-Parsons, C
Raleigh, JA
Stanbridge, EJ
Durand, RE
Banath, JP
MacPhail, SH
Olive, PL
机构
[1] British Columbia Canc Res Ctr, Dept Med Biophys, Vancouver, BC V5Z 1L3, Canada
[2] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA
[3] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA
关键词
hypoxia markers; oxygen electrode; CAIX; HIF-1; alpha; pimonidazole; cervical cancer;
D O I
10.1002/cyto.b.20086
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although tumor hypoxia has been associated with a more aggressive phenotype and lower cure rate, there is no consensus as to the method best suited for routine measurement. Binding of the chemical hypoxia marker, pimonidazole, and expression of the endogenous hypoxia markers HIF-1 alpha and CAIX were compared for their ability to detect hypoxia in tumor biopsies from 67 patients with advanced carcinoma of the cervix. Methods: Two biopsies were taken one day after administration of pimonidazole and were analyzed for pimonidazole binding using flow cytometry or immunohistochemistry. CAIX and HIF-1 alpha expression and degree of colocalization were measured in sequential antibody-stained sections. Patient subsets were examined for tumor oxygen tension using an Eppendorf electrode, S phase DNA content, or change in HIF-1 alpha expression over the course of treatment. Results: Approximately 6% of the tumor area stained positive for pimonidazole, HIF-1 alpha, or CAIX. The CAIX positive fraction correlated with the pimonidazole positive fraction (r = 0.60). Weaker but significant correlations were observed between pimonidazole and HIF-1 alpha (r = 0.31) and CAIX and HIF-1 alpha (r = 0.41). Taking the extent of marker colocalization into consideration increased the confidence that all markers were identifying hypoxic regions. Over 65% of stained areas showed a high degree of colocalization with the other markers. Oxygen microelectrode measurements and S phase fraction were not correlated with the hypoxic fraction measured using the three hypoxia markers. HIF-1 alpha levels tended to decrease with time after the start of therapy. Conclusions: Endogenous hypoxia marker binding shows reasonable agreement, in extent and location, with binding of pimonidazole. CAIX staining pattern is a better match to the pimonidazole staining pattern than is HIF-1 alpha and high CAIX expression in the absence (or low levels) of HIF-1 alpha may indicate a different biology. (c) 2006 International Society for Analytical Cytology.
引用
收藏
页码:45 / 55
页数:11
相关论文
共 45 条
[1]   GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding [J].
Airley, RE ;
Loncaster, J ;
Raleigh, JA ;
Harris, AL ;
Davidson, SE ;
Hunter, RD ;
West, CML ;
Stratford, IJ .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (01) :85-91
[2]   Oxygen tension in primary gynaecological tumours: the influence of carbon dioxide concentration [J].
Aquino-Parsons, C ;
Green, A ;
Minchinton, AI .
RADIOTHERAPY AND ONCOLOGY, 2000, 57 (01) :45-51
[3]  
Arcasoy MO, 2005, CLIN CANCER RES, V11, P20
[4]  
Azuma Y, 2003, CLIN CANCER RES, V9, P4944
[5]   Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts, effects of carbogen and nicotinamide [J].
Bussink, J ;
Kaanders, JHAM ;
Rijken, PFJW ;
Peters, JPW ;
Hodgkiss, RJ ;
Marres, HAM ;
van der Kogel, AJ .
RADIOTHERAPY AND ONCOLOGY, 1999, 50 (02) :173-184
[6]   Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers [J].
Bussink, J ;
Kaanders, JHAM ;
van der Kogel, AJ .
RADIOTHERAPY AND ONCOLOGY, 2003, 67 (01) :3-15
[7]  
De Jaeger K, 2001, BRIT J CANCER, V84, P1280
[8]   Inducible repair and the two forms of tumour hypoxia - Time for a paradigm shift [J].
Denekamp, J ;
Dasu, A .
ACTA ONCOLOGICA, 1999, 38 (07) :903-918
[9]   Cancer of the Uterine Cervix [J].
Eliane Duarte-Franco ;
Eduardo L Franco .
BMC Women's Health, 4 (Suppl 1)
[10]  
Dunn T, 1997, N C Med J, V58, P140